Matthew Russell Netherton

This inventor holds 15 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2006-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Russell Netherton. Retrieved from https://idiyas.com/inventor/matthew-russell-netherton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 13)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 6.1

ph-index = 7

Forward Citations = 97(Granted Patents)

Company Filing History:

8 out of 1,562

Boehringer Ingelheim International Gmbh

patents

7 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

Years Active: 2006-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12053473 - Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors (2024-08-06),

2. 11370771 - Inhibitors of TRPC6 (2022-06-28),

3. 10898487 - Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors (2021-01-26),

4. 9133146 - Benzodioxane inhibitors of leukotriene production (2015-09-15),

5. 8946203 - Benzodioxane inhibitors of leukotriene production (2015-02-03),

6. 8729114 - Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-S (2014-05-20),

7. 8551982 - Benzodioxane inhibitors of leukotriene production (2013-10-08),

8. 7790712 - Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors (2010-09-07),

9. 7754756 - Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions (2010-07-13),

10. 7531560 - Anti-cytokine heterocyclic compounds (2009-05-12),

11. 7514458 - Anti-cytokine heterocyclic compounds (2009-04-07),

12. 7511042 - Triazole compounds (2009-03-31),

13. 7335657 - Cytokine inhibitors (2008-02-26),

14. 7214802 - Anti-cytokine heterocyclic compounds (2007-05-08),

15. 7078419 - Cytokine inhibitors (2006-07-18),

Title: The Innovative Journey of Matthew Russell Netherton

Introduction:

Matthew Russell Netherton, a talented inventor hailing from Danbury, CT (US), has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents:

Matthew Russell Netherton's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights:

Throughout his illustrious career, Matthew Russell Netherton has been recognized for his innovative spirit and problem-solving abilities. His inventions have revolutionized various industries, earning him a reputation as a visionary inventor.

Collaborations:

Matthew Russell Netherton has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Matthew Russell Netherton's passion for innovation and his dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventions. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.